Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ARGX | A | argenx SE | -4.29 | |
CNTA | B | Centessa Pharmaceuticals plc | -3.21 | |
CNCR | C | Loncar Cancer Immunotherapy ETF | 0.00 | |
REPL | C | Replimune Group, Inc. | -1.17 | |
IMRN | C | Immuron Limited | 5.32 | |
GLSI | C | Greenwich LifeSciences, Inc. | -1.84 | |
CLDX | C | Celldex Therapeutics, Inc. | -8.42 | |
MRKR | C | Marker Therapeutics, Inc. | -4.96 | |
URGN | C | UroGen Pharma Ltd. | -1.77 | |
ORIC | C | Oric Pharmaceuticals, Inc. | -10.74 |
Related Industries: Biotechnology Broadcasting - TV Diagnostics & Research Medical Care Medical Devices Other
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IWC | B | iShares Microcap ETF | 7.0 | |
ITOT | B | iShares Core S&P Total U.S. Stock Market ETF | 2.0 | |
IWM | B | iShares Russell 2000 ETF | 2.0 | |
IWV | B | iShares Russell 3000 ETF | 2.0 | |
IWN | B | iShares Russell 2000 Value ETF | 2.0 |
Compare ETFs
- Immunotherapy
Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.
Popular Now
Recent Comments
- TraderMike on EOW Scans / Signals
- CrootsterOZ on EOW Scans / Signals
- TraderMike on Filter short-term up stocks
- CooperativeAlligator187 on Filter short-term up stocks
- TraderMike on Bollinger Band Squeeze
From the Blog
Featured Articles